This study investigates advanced/metastatic pancreatic cancer. It focuses on understanding how patients respond to different treatments based on their specific cancer profiles.
The study evaluates the effectiveness of personalized medicine using targeted treatments and chemotherapy combinations. The purpose of this study is to improve patient outcomes by selecting therapies that best match individual cancer characteristics.
- Who can participate: Adults over 18 years with advanced or metastatic pancreatic cancer may join. Participants should have a life expectancy greater than 3 months and have had no more than one prior systemic chemotherapy.
- Study details: Participants will provide tumor samples for analysis to help determine the most suitable treatment options. A placebo is not used in this study.